Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

NCT06596915 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Pancreatic Adenocarcinoma
Breast Cancer
Melanoma

Interventions

DRUG: BA1302

Sponsor

Shandong Boan Biotechnology Co., Ltd